Inito Secures $29M To Build Next-Gen AI-Engineered Home Diagnostics - News Upturn

Inito, the India-based health-tech company known for pioneering at-home hormone testing, has raised $29 million in Series B funding, marking a significant

News Upturn
Inito Raises $29M Series B to Advance AI-Powered At-Home Diagnostics – Tycoon World

Inito, the India-based health-tech company known for pioneering at-home hormone testing, has raised $29 million in Series B funding, marking a significant

Tycoon World

Did you know Preimplantation Genetic Diagnosis (PGD) & Screening (PGS) can help reduce genetic risks during IVF? At Dr. Sowjanya Aggarwal’s clinic in Delhi, we offer PGD/PGS to test embryos for genetic disorders before implantation—giving you greater peace of mind.

✅ Reduce risk of inherited disorders
✅ Improve embryo selection
✅ Personalized fertility care

#PGD #PGS #GeneticScreening #IVFDelhi
#HealthyEmbryo #FertilityTech
#IVFTreatment #FertilityCare

https://www.drsowjanyaaggarwal.com/treatments/ivf-and-infertility/pgd-pgs/